José Ángel Flores-Hernández

Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus

Samuel Treviño, Denisse Velázquez-Vázquez, Eduardo Sánchez‐Lara et al. · Oxidative Medicine and Cellular Longevity · 2016 · 64 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Hypoglycemic, lipid-lowering and metabolic regulation activities of metforminium decavanadate (H2Metf)3 [V10O28]·8H2O using hypercaloric-induced carbohydrate and lipid deregulation in Wistar rats as biological model

Samuel Treviño, Eduardo Sánchez‐Lara, Víctor Enrique Sarmiento-Ortega et al. · Journal of Inorganic Biochemistry · 2015 · 48 citations

Life Sciences, Biochemistry, Pharmacology +12

Changes on serum and hepatic lipidome after a chronic cadmium exposure in Wistar rats

Víctor Enrique Sarmiento-Ortega, Samuel Treviño, José Ángel Flores-Hernández et al. · Archives of Biochemistry and Biophysics · 2017 · 35 citations

Veterinary Medicine, Biochemistry, Toxicology +16

The NOAEL Metformin Dose Is Ineffective against Metabolic Disruption Induced by Chronic Cadmium Exposure in Wistar Rats

Víctor Enrique Sarmiento-Ortega, Eduardo Brambila, José Ángel Flores-Hernández et al. · Toxics · 2018 · 24 citations · Full text

Medicine, Pharmacology, Toxicology +17

Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(<i>N</i>,<i>N</i>-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance

Samuel Treviño, Alfonso Díaz, Eduardo Sánchez‐Lara et al. · Bioinorganic Chemistry and Applications · 2018 · 20 citations · Full text

Medicine, Pharmacology, Toxicology +13